Researchers to Congress: We Need More Funding to Fight Alzheimer’s

The disease is the sixth-leading cause of death in the U.S. and the only one of the top 10 without a treatment.

National Journal
Sarah Mimms
Add to Briefcase
See more stories about...
Sarah Mimms
Feb. 27, 2014, midnight

Sen. Tom Har­kin led mem­bers of a Sen­ate Ap­pro­pri­ations sub­com­mit­tee in a hear­ing Wed­nes­day on the eco­nom­ic im­pact of Alzheimer’s dis­ease, as Con­gress works with the med­ic­al com­munity to real­ize the Obama ad­min­is­tra­tion’s am­bi­tious goal of cur­ing the ail­ment by 2025.

The sub­com­mit­tee ques­tioned lead­ers from the Na­tion­al In­sti­tutes of Health and the Na­tion­al In­sti­tute of Aging, along with oth­er ex­perts. Oth­er wit­nesses in­cluded a comedi­an and Alzheimer’s act­iv­ist Seth Ro­gen, who brought a little star power — and lev­ity — to the pro­ceed­ings which were, need­less to say, pretty grim.

Though Alzheimer’s is the sixth-lead­ing cause of death in the United States, it isn’t as com­monly dis­cussed or as well fun­ded as some of the oth­er dis­eases, sev­er­al re­search­ers test­i­fied. Worse, it is the only one of the top 10 dead­li­est dis­eases in the na­tion for which there is no treat­ment to slow its pro­gress. There is no cure and it is al­ways fatal.

And the dis­ease is grow­ing rap­idly, as are the costs as­so­ci­ated with caring for pa­tients. Care for those suf­fer­ing from Alzheimer’s and oth­er types of de­men­tia is ex­pec­ted to grow from $203 bil­lion last year to $1.2 tril­lion by 2050, ac­cord­ing to Har­kin’s of­fice. Medi­care and Medi­caid costs as­so­ci­ated with the dis­ease could grow by as much as 500 per­cent over the same peri­od.

As such, ap­pro­pri­at­ors in­cluded ma­jor fund­ing for med­ic­al re­search in their fisc­al year 2014 spend­ing bill, which passed both cham­bers in Janu­ary. The bill in­cludes an $80 mil­lion in­crease, com­pared with 2012, in fund­ing for Alzheimer’s pre­ven­tion and re­search at the Na­tion­al In­sti­tute on Aging, which is part of NIH.

Sen. Bar­bara Mikul­ski, D-Md., who chairs the Ap­pro­pri­ations Com­mit­tee, noted in her ques­tion­ing that her own fath­er died of Alzheimer’s. She asked them what Con­gress could do to help find a cure.

“I think we are not at the mo­ment lim­ited by ideas. We’re not lim­ited by sci­entif­ic op­por­tun­it­ies, we’re not lim­ited by tal­ent, we’re un­for­tu­nately lim­ited by re­sources to move this en­ter­prise for­ward at the pace that it could take,” NIH Dir­ect­or Fran­cis Collins told the sen­at­or. He poin­ted out that the fund­ing for Alzheimer’s re­search is min­im­al poor that just one out of every six sci­ent­ists with a prom­ising re­search idea will ac­tu­ally get the money for it.

That got Ro­gen — who peppered the story of his moth­er-in-law’s early dia­gnos­is at the age of 55 with jokes — go­ing. He warned that without bet­ter fund­ing, re­search­ers with ideas for an Alzheimer’s cure might choose to study something “sex­i­er,” like heart dis­ease. The lack of fund­ing shows “people of my gen­er­a­tion,” Ro­gen said, “that it’s just not that high a pri­or­ity on the na­tion­al level.”

Former Rep. Den­nis Moore, D-Kan­sas, also called for more re­search fund­ing at the hear­ing. Moore, who left Con­gress in 2011, was dia­gnosed with Alzheimer’s dis­ease him­self shortly there­after and has since be­come an ad­voc­ate. He noted that NIH spend­ing for Alzheimer’s re­search has lagged (a point that also found its way in­to a de­bate on this sea­son’s House of Cards, as the dis­ease be­gins to gain more prom­in­ence). “The dir­ect cost of Alzheimer’s and re­lated de­men­tia is great­er than any oth­er con­di­tion in the United States, in­clud­ing heart dis­ease and can­cer,” Moore said, cit­ing a study pub­lished by the New Eng­land Journ­al of Medi­cine.

But Collins and oth­ers poin­ted to a pos­it­ive sign for re­search­ers: the Ac­cel­er­at­ing Medi­cines Part­ner­ship, which was formed by NIH earli­er this month to com­bat Alzheimer’s and oth­er dis­eases. The ven­ture rep­res­ents an “un­pre­ced­en­ted” level of co­oper­a­tion between 10 phar­ma­ceut­ic­al com­pan­ies — in­clud­ing gi­ants like Pf­izer, Glaxo­S­mithK­line, and John­son & John­son — as well as sev­er­al non­profit groups, NIH, and the Food and Drug Ad­min­is­tra­tion.

The 10 com­pan­ies have kicked in a total of $61.9 mil­lion, with NIH of­fer­ing an­oth­er $67.6 mil­lion, to re­search and pro­duce Alzheimer’s med­ic­a­tions with­in the next five years. Alzheimer’s was one of the few dis­eases that was big enough to bring all 10 usu­ally com­pet­ing com­pan­ies — and their cash — to the table, Collins said.

The pro­ject is part of a lar­ger fed­er­al goal to find a cure for the dis­ease by 2025. Be­fore Con­gress boos­ted its fund­ing in Janu­ary, NIH had planned to spend about $562 mil­lion on Alzheimer’s re­search this year, com­pared to nearly $10 bil­lion for can­cer and al­most $2 bil­lion for heart dis­ease.

Still, Na­tion­al In­sti­tute on Aging Dir­ect­or Richard Hodes said the goal is at­tain­able. “Am­bi­tious as it is, we have no choice,” he said, not­ing the grow­ing “ur­gency” of the is­sue as the Amer­ic­an pop­u­la­tion ages.

What We're Following See More »
THE PLAN ALL ALONG?
Manchin Drops Objections, Clearing Way for Spending Deal
4 hours ago
THE LATEST

"The Senate standstill over a stopgap spending bill appeared headed toward a resolution on Friday night. Senators who were holding up the measure said votes are expected later in the evening. West Virginia Democrat Joe Manchin had raised objections to the continuing resolution because it did not include a full year's extension of retired coal miners' health benefits," but Manchin "said he and other coal state Democrats agreed with Senate Democratic leaders during a caucus meeting Thursday that they would not block the continuing resolution, but rather use the shutdown threat as a way to highlight the health care and pension needs of the miners."

Source:
UNCLEAR WHAT CAUSED CHANGE OF HEART
Giuliani Out of Running For State
7 hours ago
BREAKING

Donald Trump transition team announced Friday afternoon that top supporter Rudy Giuliani has taken himself out of the running to be in Trump's cabinet, though CNN previously reported that it was Trump who informed the former New York City mayor that he would not be receiving a slot. While the field had seemingly been narrowed last week, it appears to be wide open once again, with ExxonMobil CEO Rex Tillerson the current favorite.

Source:
BEGINS AT MIDNIGHT ABSENT SENATE ACTION
Feds Begin Prepping for Government Shutdown
8 hours ago
THE LATEST

Given the Senate's inaction on the continuing budget resolution (so far), the White House "said it has begun to work with agencies to prepare for the possibility of a large swath of the federal workforce being furloughed without pay beginning at midnight." Even if a shutdown occurs, however, "Senate procedures will allow the chamber to approve the CR with only a handful of Democrats in support by Sunday morning. Of the roughly 900,000 federal employees who were subject to furloughs in agencies’ most recent calculations, most would not be materially impacted as they do not work on weekends."

Source:
ALSO VICE-CHAIR OF TRUMP’S TRANSITION TEAM
Trump Taps Rep. McMorris Rodgers for Interior Secretary
12 hours ago
BREAKING
SHUTDOWN LOOMING
House Approves Spending Bill
1 days ago
BREAKING

The House has completed it's business for 2016 by passing a spending bill which will keep the government funded through April 28. The final vote tally was 326-96. The bill's standing in the Senate is a bit tenuous at the moment, as a trio of Democratic Senators have pledged to block the bill unless coal miners get a permanent extension on retirement and health benefits. The government runs out of money on Friday night.

×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login